Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1791 1
1792 1
1794 1
1800 2
1807 2
1808 2
1814 1
1819 1
1831 1
1842 1
1845 1
1850 2
1895 1
1897 1
1903 2
1904 3
1906 2
1907 3
1908 1
1909 1
1911 6
1912 4
1913 2
1914 3
1915 5
1916 3
1917 1
1919 4
1920 3
1921 3
1923 2
1924 3
1925 6
1926 8
1927 3
1928 3
1929 5
1930 3
1931 4
1932 3
1933 4
1934 6
1935 7
1936 2
1937 2
1938 3
1939 2
1940 4
1941 4
1942 6
1943 1
1944 5
1945 2
1946 15
1947 21
1948 28
1949 11
1950 28
1951 38
1952 48
1953 43
1954 40
1955 47
1956 35
1957 38
1958 48
1959 32
1960 42
1961 49
1962 33
1963 52
1964 67
1965 53
1966 48
1967 56
1968 68
1969 71
1970 81
1971 72
1972 83
1973 78
1974 101
1975 97
1976 95
1977 103
1978 100
1979 86
1980 94
1981 79
1982 89
1983 111
1984 111
1985 144
1986 127
1987 173
1988 170
1989 188
1990 209
1991 238
1992 248
1993 309
1994 271
1995 305
1996 294
1997 248
1998 275
1999 300
2000 314
2001 316
2002 351
2003 401
2004 430
2005 477
2006 536
2007 542
2008 614
2009 629
2010 698
2011 809
2012 877
2013 970
2014 1116
2015 1198
2016 1314
2017 1254
2018 1299
2019 1399
2020 816
Text availability
Article attribute
Article type
Publication date

Search Results

20,621 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Mugaya
Page 1
Safety and Efficacy of High-Dose Unfractionated Heparin for Prevention of Venous Thromboembolism in Overweight and Obese Patients.
Joy M, Tharp E, Hartman H, Schepcoff S, Cortes J, Sieg A, Mariski M, Lee Y, Murphy M, Ranjbar G, Sharaf S, Yau G, Choi HA, Samuel S. Joy M, et al. Pharmacotherapy. 2016 Jul;36(7):740-8. doi: 10.1002/phar.1775. Epub 2016 Jun 29. Pharmacotherapy. 2016. PMID: 27265806
Pharmacologic Management of Paroxysmal Sympathetic Hyperactivity After Brain Injury.
Samuel S, Allison TA, Lee K, Choi HA. Samuel S, et al. J Neurosci Nurs. 2016 Apr;48(2):82-9. doi: 10.1097/JNN.0000000000000207. J Neurosci Nurs. 2016. PMID: 26954919 Review.
Medico-legal.
Samuel S. Samuel S. Aust J Gen Pract. 2019 Jan-Feb;48(1-2):5. doi: 10.31128/AJGP-01-19-1234e. Aust J Gen Pract. 2019. PMID: 31256454 No abstract available.
Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study.
Samuel S, Allison TA, Sharaf S, Yau G, Ranjbar G, Mckaig N, Nguyen A, Escobar M, Choi HA. Samuel S, et al. J Clin Pharm Ther. 2016 Oct;41(5):499-502. doi: 10.1111/jcpt.12415. Epub 2016 Jul 6. J Clin Pharm Ther. 2016. PMID: 27381025 Clinical Trial.
Intrapartum Synthetic Oxytocin and Its Effects on Maternal Well-Being at 2 Months Postpartum.
Gu V, Feeley N, Gold I, Hayton B, Robins S, Mackinnon A, Samuel S, Carter CS, Zelkowitz P. Gu V, et al. Birth. 2016 Mar;43(1):28-35. doi: 10.1111/birt.12198. Epub 2015 Nov 10. Birth. 2016. PMID: 26554749
CONCLUSIONS: The widespread use of synOT in managed labor warrants caution, as the influence of synOT on a new mother's well-being is evident at 2 months postpartum....
CONCLUSIONS: The widespread use of synOT in managed labor warrants caution, as the influence of synOT on a new mother's well-being is …
Hajdu Cheney Syndrome.
Samuel SS, Shetty S, Arunachal G, Koshy S, Paul TV. Samuel SS, et al. J Clin Diagn Res. 2016 Feb;10(2):OD07-9. doi: 10.7860/JCDR/2016/15782.7203. Epub 2016 Feb 1. J Clin Diagn Res. 2016. PMID: 27042504 Free PMC article.
GDPR confusion.
Harris D, Samuel S, Probert E. Harris D, et al. Vet Rec. 2018 Sep 29;183(12):388. doi: 10.1136/vr.k3956. Vet Rec. 2018. PMID: 30266857 No abstract available.
Considering domestic violence in clinical practice.
Samuel S. Samuel S. Aust Fam Physician. 2016 Apr;45(4):165. Aust Fam Physician. 2016. PMID: 27505919 No abstract available.
Editorial: What brings you here today?
Samuel S. Samuel S. Aust J Gen Pract. 2018 Apr;47(4):167. doi: 10.31128/AJGP-04-18-1234e. Aust J Gen Pract. 2018. PMID: 29621853 No abstract available.
Ustekinumab: a novel therapeutic option in Crohn's disease.
Simon EG, Samuel S, Ghosh S, Moran GW. Simon EG, et al. Expert Opin Biol Ther. 2016 Aug;16(8):1065-74. doi: 10.1080/14712598.2016.1205582. Expert Opin Biol Ther. 2016. PMID: 27341173 Review.
INTRODUCTION: Although anti-tumour necrosis factor (TNF) agents have caused a paradigm shift in the management of moderate-to-severe Crohn's, they are sometimes associated with diminished or absent response in a considerable proportion of patients. ...EXPERT OPINION: Curre …
INTRODUCTION: Although anti-tumour necrosis factor (TNF) agents have caused a paradigm shift in the management of moderate-to-severe Crohn' …
20,621 results
Jump to page
Feedback